Markedly T2-Hypointense Clival Plasmacytoma With Light Chain Deposition Disease: A Case Report

Plasmacytomas are rare monoclonal neoplastic plasma cell proliferations in soft tissue or bone, with clival plasmacytomas being extremely rare and occasionally presenting with light chain deposition disease (LCDD). While imaging findings for clival plasmacytomas have shown variable T2 signal characteristics, complete T2 signal loss has not been previously reported. We present a case of a 61-year-old female found to have a 1.9 cm expansile lytic lesion in the clivus on CT. MRI revealed intermediate T1 signal and near-complete T2 signal loss. Histopathology demonstrated kappa-restricted plasma cells with extracellular light chain deposition, while bone marrow biopsy showed 5-10% plasma cells without evidence of multiple myeloma. The patient was diagnosed with a solitary plasmacytoma of the clivus with associated LCDD and underwent endoscopic resection and radiotherapy, showing a favorable initial response at a seven-month follow-up. This case highlights the importance of considering plasmacytoma with associated LCDD for marked T2 hypointense, enhancing skull base lesions. The combination of plasmacytoma and LCDD may explain the unusual imaging characteristics, underscoring the need for comprehensive diagnostic approaches in patients presenting with unusually hypointense clival lesions.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-12-23
DOI
https://doi.org/10.7759/cureus.76289
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Markedly T2-Hypointense Clival Plasmacytoma With Light Chain Deposition Disease: A Case Report

Samuel N Rogers, Conner D. Reynolds, Ricardo Garcı́a, D. Fuchs et al.
Cureus
Multiple Myeloma Research and Treatments
article

Markedly T2-Hypointense Clival Plasmacytoma With Light Chain Deposition Disease: A Case Report

Samuel N Rogers, Conner D. Reynolds, Ricardo Garcı́a, D. Fuchs, Tiffany Shamas, Rosalie Doescher
article en

Abstract

Plasmacytomas are rare monoclonal neoplastic plasma cell proliferations in soft tissue or bone, with clival plasmacytomas being extremely rare and occasionally presenting with light chain deposition disease (LCDD). While imaging findings for clival plasmacytomas have shown variable T2 signal characteristics, complete T2 signal loss has not been previously reported. We present a case of a 61-year-old female found to have a 1.9 cm expansile lytic lesion in the clivus on CT. MRI revealed intermediate T1 signal and near-complete T2 signal loss. Histopathology demonstrated kappa-restricted plasma cells with extracellular light chain deposition, while bone marrow biopsy showed 5-10% plasma cells without evidence of multiple myeloma. The patient was diagnosed with a solitary plasmacytoma of the clivus with associated LCDD and underwent endoscopic resection and radiotherapy, showing a favorable initial response at a seven-month follow-up. This case highlights the importance of considering plasmacytoma with associated LCDD for marked T2 hypointense, enhancing skull base lesions. The combination of plasmacytoma and LCDD may explain the unusual imaging characteristics, underscoring the need for comprehensive diagnostic approaches in patients presenting with unusually hypointense clival lesions.

CureusVol. 16(12)
University of Arizona (US), Banner - University Medical Center Tucson (US)
Zero hunger
Openalex Percentile: Top 56%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.